Zhengbin Zhu Selected Research

Myocardial Infarction

1/2023	[68Ga]Ga-DOTA-FAPI-04 PET/MR in patients with acute myocardial infarction: potential role of predicting left ventricular remodeling.
1/2022	Percutaneous Ventricular Restoration Prevents Left Ventricular Remodeling Post Myocardial Infarction: One-Year Evaluation of the Heartech First-in-man Study.
9/2021	A randomized comparison of a novel iopromide-based paclitaxel-coated balloon Shenqi versus SeQuent Please for the treatment of in-stent restenosis.
1/2021	Oncostatin M promotes infarct repair and improves cardiac function after myocardial infarction.
1/2020	Serum MG53/TRIM72 Is Associated With the Presence and Severity of Coronary Artery Disease and Acute Myocardial Infarction.
1/2020	Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction.
11/2019	First-in-man study of Heartech® percutaneous left ventricular partitioning device for treatment of heart failure postmyocardial infarction.
1/2015	Acute administration of n-3 rich triglyceride emulsions provides cardioprotection in murine models after ischemia-reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhengbin Zhu Research Topics

Disease

8	Myocardial Infarction 01/2023 - 01/2015
3	Atherosclerosis 10/2023 - 11/2022
3	Chronic Renal Insufficiency 10/2023 - 12/2014
3	Ischemia 02/2023 - 08/2012
3	Infarction (Infarctions) 01/2021 - 01/2015
3	Stroke (Strokes) 01/2020 - 03/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2023 - 02/2019
2	ST Elevation Myocardial Infarction 09/2023 - 01/2023
2	Inflammation (Inflammations) 11/2022 - 04/2010
2	Heart Failure 01/2022 - 01/2020
2	Thrombosis (Thrombus) 01/2020 - 03/2019
2	Hemorrhage 11/2019 - 03/2019
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2016 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2015 - 12/2014
2	Reperfusion Injury 01/2015 - 04/2010
1	Pathologic Constriction (Stenosis) 01/2023
1	Ventricular Remodeling 01/2023
1	Coronary Stenosis (Coronary Artery Stenosis) 01/2021
1	Diabetes Mellitus 01/2020
1	Neointima 01/2020
1	Cicatrix (Scar) 01/2020
1	Renal Insufficiency (Renal Failure) 11/2019
1	Necrosis 01/2017
1	Cardiotoxicity 06/2015
1	Peripheral Arterial Disease 01/2015
1	Body Weight (Weight, Body) 01/2015
1	Death (Near-Death Experience) 12/2014
1	Hypoxia (Hypoxemia) 04/2010

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2022
2	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2020
2	omega-Chloroacetophenone (Mace)IBA 01/2020 - 12/2014
2	Sulfates (Sulfates, Inorganic)IBA 06/2015 - 12/2014
1	Tyrosine (L-Tyrosine)FDA Link 10/2023
1	tyrosine O-sulfateIBA 10/2023
1	Chemokine ReceptorsIBA 10/2023
1	B-Cell Activating FactorIBA 02/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	Complement System Proteins (Complement)IBA 11/2022
1	shenqiIBA 09/2021
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	Oncostatin MIBA 01/2021
1	poly(lactide) (polylactic acid)IBA 01/2021
1	ImmunosorbentsIBA 01/2020
1	EnzymesIBA 01/2020
1	zotarolimusIBA 01/2020
1	CollagenIBA 01/2020
1	Lipase (Acid Lipase)FDA Link 02/2019
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 02/2019
1	CC ChemokinesIBA 01/2017
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2017
1	Therapeutic UsesIBA 02/2016
1	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2015
1	Triglycerides (Triacylglycerol)IBA 01/2015
1	EmulsionsIBA 01/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2015
1	Uremic ToxinsIBA 12/2014
1	Glycogen Synthase (Synthase I)IBA 08/2012
1	Aldehyde Reductase (Aldose Reductase)IBA 08/2012
1	Advanced Glycation End ProductsIBA 04/2010
1	Glycogen Synthase Kinase 3 betaIBA 04/2010
1	LigandsIBA 04/2010

Therapy/Procedure

4	Stents 01/2023 - 01/2015
3	Therapeutics 01/2022 - 01/2015
1	Percutaneous Coronary Intervention 09/2023
1	Patient Readmission 01/2020
1	Renal Dialysis (Hemodialysis) 11/2019
1	Transplantation 02/2016